Optimized cyclin D1 immunoperoxidase staining in mantle cell lymphoma

Applied Immunohistochemistry

Volumn 8, Issue 1, 2000, Pages 57-60

  Korin, Hope W ^a   Schwartz, Mary R ^a   Chirala, Mini ^a   Younes, Mamoun ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cyclin D1; Immunohistochemistry; MALT; Mantle cell; Marginal zone; Technique

Indexed keywords

CYCLIN D1; PEROXIDASE;

ANTIGEN RETRIEVAL; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; CYCLIN D1; DIAGNOSIS, DIFFERENTIAL; EVALUATION STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, MANTLE-CELL; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; SPLENIC NEOPLASMS;

EID: 0034064325     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200003000-00009     Document Type: Article

References (38)

1. Shivdasani RA, Hess JL, Skarin AT, Pinkus GS. Intermediate lymphocyte lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma [see comments]. J Clin Oncol 1993;11:802-11.
2. Pittaluga S, Wlodarska I, Stul MS, et al. Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology 1995;26:17-24.
3. Fraga M, Lloret E, Sanchez-Verde L, et al. Mucosal mantle cell (centrocytic) lymphomas. Histopathology 1995;26:413-22.
4. Majlis A, Pugh WC, Rodriguez MA, Benedict WF, Cabanillas F. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol 1997; 15:1664-71.
5. Yatabe Y, Nakamura S, Nakamura T, et al. Multiple polypoid lesions of primary mucosa-associated lymphoid-tissue lymphoma of colon. Histopathology 1998;32:116-25.
6. Ott G, Kalla J, Hanke A, et al. The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features. Leuk Lymphoma 1998;32:55-63.
7. Campo E, Raffeld M, Jaffe ES. Mantle-cell lymphoma. Semin Hematol 1999;36:115-27.
8. Vahdati M, Graafland H, Emberger JM. 11;14 translocations in lymphoproliferative disorders. An analysis of three cases. Acta Haematol 1983;70:130-3.
9. Erikson J, Finan J, Tsujimoto Y, Nowell PC, Croce CM. The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus. Proc Natl Acad Sci USA 1984;81:4144-8.
10. Medeiros LJ, Van Krieken JH, Jaffe ES, Raffeld M. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood 1990;76:2086-90.
11. Williams ME, Meeker TC, Swerdlow SH. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood 1991;78:493-8.
12. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res 1992;52 (suppl 19):541s-4s.
13. Seto M, Yamamoto K, Iida S, et al. Gene rearrangement and over-expression of PRAD1 in lymphoid malignancy with t(11;14)-(q13;q32) translocation. Oncogene 1992;7:1401-6.
14. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 1993;7:241-S.
15. Rimokh R, Berger F, Delsol G, et al. Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 1993;81: 3063-7.
16. Williams ME, Swerdlow SH, Meeker TC. Chromosome t(11;14) (q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia 1993;7: 1437-40.
17. Oka K, Ohno T, Kita K, et al. PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma. Br J Haematol 1994;86: 786-91.
18. Komatsu H, Iida S, Yamamoto K, et al. A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene. Blood 1994;84:1226-31.
19. Akiyama N, Tsuruta H, Sasaki H, et al. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32). Cancer Res 1994; 54:377-9.
20. Bosch F, Jares P, Campo E, et al. PRAD-1/cyclin D1 gene over-expression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994;84:2726-32.
21. de Boer CJ, van Krieken JH, Kluin-Nelemans HC, Kluin PM, Schuuring E. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 1995;10:1833-40.
22. Banno S, Yoshikawa K, Nakamura S, et al. Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus. Jpn J Cancer Res 1994; 85:918-26.
23. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994;145:86-96.
24. Williams ME, Swerdlow SH. Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement. Ann Oncol 1994;5(suppl 1):71-3.
25. Nakamura S, Seto M, Banno S, et al. Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma. Jpn J Cancer Res 1994;85: 1270-9.
26. Kuroda H, Komatsu H, Nakamura S, et al. The positive nuclear staining observed with monoclonal antibody against PRAD1/ cyclin D1 correlates with mRNA expression in mantle cell lymphoma. Jpn J Cancer Res 1995;86:890-8.
27. Hashimoto Y, Nakamura N, Kuze T, Ono N, Abe M. Multiple lymphomatous polyposis of the gastrointestinal tract is a heterogenous group that includes mantle cell lymphoma and follicular lymphoma: analysis of somatic mutation of immunoglobulin heavy chain gene variable region. Hum Pathol 1999;30:581-7.
28. Kumar S, Krenacs L, Otsuki T, et al. bcl-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. Am J Clin Pathol 1996;105:737-43.
29. de Boer CJ, Schuuring E, Dreef E, et al. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995;86:2715-23.
30. Swerdlow SH, Yang WI, Zukerberg LR, Harris NL, Arnold A, Williams ME. Expression of cyclin D1 protein in centrocytic/ mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Hum Pathol 1995;26:999-1004.
31. Zukerberg LR, Yang WI, Arnold A, Harris NL. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am J Clin Pathol 1995;103:756-60.
32. Ott MM, Helbing A, Ott G, et al. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol 1996; 179:238-42.
33. Nakamura S, Yatabe Y, Kuroda H, et al. Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma. Leukemia 1997:11(suppl 3):536-7.
34. Vasef MA, Medeiros LJ, Koo C, McCourty A, Brynes RK. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow. Am J Clin Pathol 1997;108:302-7.
35. Brynes R, McCourty A, Tamayo R, Jenkins K, Battifora H. Demonstration of cyclin D1 (bc11) in mantle cell lymphoma: enhanced staining using heat and ultrasound epitope retrieval. Appl Immunohistochem 1997;5:45-8.
36. de Leon ED, Alkan S, Huang JC, Hsi ED. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes. Mod Pathol 1998;11:1046-51.
37. Savilo E, Campo E, Mollejo M, et al. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma. Mod Pathol 1998; 11:601-6.
38. Chan JK, Miller KD, Munson P, Isaacson PG. Immunostaining for cyclin D1 and the diagnosis of mantle cell lymphoma: is there a reliable method? Histopathology 1999;34:266-70.